Suanfarma Suanfarma

X

Find the latest Drugs in Development and Pipeline Prospector News of Curacle.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Curacle
korearepublicofnew Flag
Country
Country
South Korea
Address
Address
Ga dong #608~611, Business growth support center, 54, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, Korea
Telephone
Telephone
+82-31-706-8300
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Under the agreement, CURACLE will retain the marketing rights of CU06-RE, the first orally administered treatment for diabetic macular edema and wet-AMD in all Asia countries while Théa will have the marketing rights in all other countries around the world.


Lead Product(s): CU06

Therapeutic Area: Ophthalmology Product Name: CU06-RE

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: Théa Open Innovation

Deal Size: $2,163.5 million Upfront Cash: $6.0 million

Deal Type: Collaboration October 27, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY